General Medicines, Commercial Director, Menopause
Pfizer
September 02, 2026
Remote friendly (Lake Forest, IL)
United States
Sales
General Medicines, Commercial Director – Menopause Portfolio (PAVE)
Responsibilities:
- Own menopause portfolio strategy (franchise and brand-level) using customer insight, performance targets, and market realities.
- Serve as brand steward and cross-functional connector (align teams, clarify decisions, remove roadblocks).
- Enable a first-in-industry partnership model with internal/external stakeholders to create patient and business value.
- Lead end-to-end externalized content development, including MLR (HCP/patient materials aligned to strategy, compliant, and timely).
- Manage day-to-day engagement with 3rd-party partner (Indegene) across menopause brands (expectations, quality, delivery tracking).
- Drive portfolio prioritization across initiatives and investments (make resource-impact tradeoffs).
- Set and deliver portfolio commercial strategy; align brand plans to PAVE priorities and enterprise goals; convert strategy to measurable execution.
- Build and align stakeholder network (medical, access, legal/regulatory, agencies/partners) to achieve brand goals.
- Share learnings across the PAVE community; standardize what works; drive simplification/efficiencies.
- Act as a visible, trusted leader with strong judgment and storytelling.
Minimum Requirements:
- BA/BS + 8 years; MBA/MS + 7; PhD/JD + 5; or MD/DVM + 4 (pharmaceutical commercialization strategy/leadership).
- Brand management experience; proven pharmaceutical commercial strategy development.
- Strong analytical skills; lead cross-functional teams; excellent project management.
- Market analysis/forecasting; regulatory familiarity; stakeholder engagement/relationship management.
- Proficiency using GCMA for promotional material review/approval.
- Comfort using AI tools.
Preferred Requirements:
- Leadership/stakeholder engagement; adaptability; proactive problem-solving; communication/presentation.
- Patient-centric mindset; collaboration/influence/negotiation; emotional intelligence; resilience.
Application:
- Apply by September 16, 2026. Travel: 10%.
Responsibilities:
- Own menopause portfolio strategy (franchise and brand-level) using customer insight, performance targets, and market realities.
- Serve as brand steward and cross-functional connector (align teams, clarify decisions, remove roadblocks).
- Enable a first-in-industry partnership model with internal/external stakeholders to create patient and business value.
- Lead end-to-end externalized content development, including MLR (HCP/patient materials aligned to strategy, compliant, and timely).
- Manage day-to-day engagement with 3rd-party partner (Indegene) across menopause brands (expectations, quality, delivery tracking).
- Drive portfolio prioritization across initiatives and investments (make resource-impact tradeoffs).
- Set and deliver portfolio commercial strategy; align brand plans to PAVE priorities and enterprise goals; convert strategy to measurable execution.
- Build and align stakeholder network (medical, access, legal/regulatory, agencies/partners) to achieve brand goals.
- Share learnings across the PAVE community; standardize what works; drive simplification/efficiencies.
- Act as a visible, trusted leader with strong judgment and storytelling.
Minimum Requirements:
- BA/BS + 8 years; MBA/MS + 7; PhD/JD + 5; or MD/DVM + 4 (pharmaceutical commercialization strategy/leadership).
- Brand management experience; proven pharmaceutical commercial strategy development.
- Strong analytical skills; lead cross-functional teams; excellent project management.
- Market analysis/forecasting; regulatory familiarity; stakeholder engagement/relationship management.
- Proficiency using GCMA for promotional material review/approval.
- Comfort using AI tools.
Preferred Requirements:
- Leadership/stakeholder engagement; adaptability; proactive problem-solving; communication/presentation.
- Patient-centric mindset; collaboration/influence/negotiation; emotional intelligence; resilience.
Application:
- Apply by September 16, 2026. Travel: 10%.